Ownership history in MPM BioImpact LLC · 8 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Trevi Therapeutics Inc (TRVI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 3,287,087 | -119,868 | -3.5% | 4.71% | $41.2M | $12.52 |
| 2025 Q3 | UNCHANGED | 3,406,955 | — | 0% | 5.10% | $31.2M | $9.15 |
| 2025 Q2 | REDUCED | 3,406,955 | -21,411 | -0.6% | 3.23% | $18.6M | $5.47 |
| 2025 Q1 | ADDED | 3,428,366 | +333,470 | +10.8% | 3.71% | $21.6M | $6.29 |
| 2024 Q4 | ADDED | 3,094,896 | +1,556,379 | +101.2% | 1.81% | $12.8M | $4.12 |
| 2024 Q3 | ADDED | 1,538,517 | +28,343 | +1.9% | 0.77% | $5.1M | $3.34 |
| 2024 Q2 | ADDED | 1,510,174 | +169,214 | +12.6% | 0.70% | $4.5M | $2.98 |
| 2024 Q1 | INITIATED | 1,340,960 | — | — | 0.74% | $4.6M | — |
As of 2025 Q4 — sorted by position size